SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Venus Remedies reports marginal rise in Q1 net profit

06 Aug 2012 Evaluate

Venus Remedies has reported results for first quarter ended June 30, 2012.

The company has registered a rise of 3.16% in its net profit at Rs 14.05 crore for the quarter under review as compared to Rs 13.62 crore for the same quarter in the previous year. The total income from operation of the company has increased by 13.60% at Rs 112.57 crore for Q1FY13 as compared Rs 99.09 crore for the corresponding quarter previous year.

Venus Remedies Share Price

1895.50 7.85 (0.42%)
16-Jun-2026 11:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1798.85
Dr. Reddys Lab 1274.90
Cipla 1382.90
Zydus Lifesciences 1077.50
Lupin 2263.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: